Novartis Ties Up With Regenerex Zacks.com ... with privately-held biopharmaceutical company, Regenerex. As per the agreement, Novartis will gain access to Regenerex's proprietary stem cell based therapy platform Facilitating Cell Therapy (FCRx) which is being evaluated for kidney transplantation. |